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Abstract: Sex-related differences in lipid availability and fatty acid composition during swine foetal
development were investigated. Plasma cholesterol and triglyceride concentrations in the mother
were strongly related to the adequacy or inadequacy of foetal development and concomitant activation
of protective growth in some organs (brain, heart, liver and spleen). Cholesterol and triglyceride
availability was similar in male and female offspring, but female foetuses showed evidence of
higher placental transfer of essential fatty acids and synthesis of non-essential fatty acids in muscle
and liver. These sex-related differences affected primarily the neutral lipid fraction (triglycerides),
which may lead to sex-related postnatal differences in energy partitioning. These results illustrate
the strong influence of the maternal lipid profile on foetal development and homeorhesis, and they
confirm and extend previous reports that female offspring show better adaptive responses to maternal
malnutrition than male offspring. These findings may help guide dietary interventions to ensure
adequate fatty acid availability for postnatal development.
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1. Introduction
Prenatal development of humans and animals requires adequate placental supply of oxygen and
nutrients [1,2], which, in turn, requires adequate maternal nutrition and placental function. Inadequate
placental nutrient supply leads to intrauterine growth restriction (IUGR), resulting in newborns that
are small for their gestational age. Such offspring may be predisposed to perinatal morbidity and
mortality [3] as well as lifelong chronic non-communicable disorders such as obesity, type II diabetes,
hypertension and cardiovascular diseases [4–7].
Among humans, IUGR due to maternal malnutrition shows a much higher incidence in
resource-challenged areas (15%) than in developed areas (6%) [8,9]. In recent years, incidence has been
increasing in developed countries because of maternal eating disorders, voluntary intake restriction for
aesthetic reasons [10] and abnormal placental development leading to placental insufficiency [11]. This
abnormal placental development has been associated with postponement of childbearing, inadequate
lifestyle and maternal and gestational factors [8,12,13].
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Previous studies from our group using a swine model of IUGR have highlighted the importance
of maternal nutrition for proper foetal development. Maternal malnutrition compromises foetal
metabolism and development, causing growth retardation and triggering adaptive changes in the
foetus to increase likelihood of survival [14]. Work from other groups has shown that the maternal lipid
profile and placental efficiency are strongly related to cholesterol and triglyceride availability for human
and other animal foetuses, which affects their viability and growth [15–20]. The developing foetus
requires substantial amounts of lipids, mainly polyunsaturated fatty acids (PUFA), the availability
of which is determined largely by maternal circulating levels and placental transfer [21]. Impaired
placental transfer of PUFA causes or exacerbates IUGR [21–23] and may be caused by lipid peroxidation
or other forms of oxidative stress [24,25].
Extensive research in humans and animal models has shown that the sex of the offspring can
affect pre- and postnatal development in compromised pregnancies such as IUGR [14,26–31]. Less
clear is whether this sex effect extends to lipid homeorhesis. Therefore the present study exploited the
power of the pig as a translational model [32] to investigate sex-related differences in lipid availability
and fatty acid composition during foetal development. The pig, like humans, is omnivorous and prone
to sedentary behaviour and obesity, and the metabolism, cardiovascular system and relative organ
sizes in pigs are similar to those in humans [33–36]. A further advantage of studying swine is that
insights will impact not only research but also farm productivity. IUGR occurs often in swine because
of inadequate maternal nutrition or placental insufficiency [2,37,38], and it limits farm profitability [14].
2. Results
Foetuses were obtained from five sows on Gestational Day (GD) 70 (n = 33) or from four sows on
GD 90 (n = 23). The average number of foetuses per sow was 6.8 ± 3.8 on GD 70 and 5.8 ± 3.6 on GD
90. Of the 56 foetuses, 23 were female, of which 13 were recovered on GD 70 and 10 on GD 90; among
the 33 male foetuses, 20 were recovered on GD 70 and 13 on GD 90. Hence, the sex ratio was close to
1:1, with males accounting for 57.7% of GD 70 foetuses and 56.5% of GD 90 foetuses. Evidence of IUGR
was found in eight pregnancies, affecting four GD 70 foetuses (11%) and four GD 90 foetuses (17.4%).
2.1. Effects of Maternal Metabolic Status on Foetal Development
The size and weight of normal (non-IUGR) foetuses increased with gestational age (Table 1), as
did development of the placenta, liver, kidney and intestine, based on histology (all p < 0.0001).
In these normal foetuses, body development correlated strongly with maternal lipid profile
depicted in Figure 1. Specifically, lower maternal plasma cholesterol concentrations correlated with
lower foetal body weight (r = 0.777, p < 0.05) and corpulence in terms of trunk length (r = 0.832),
thoracic circumference (r = 0.808) and abdominal circumference (r = 0.958) (all p < 0.01). Lower maternal
plasma cholesterol concentrations also correlated with higher ratios of organ-to-body weight for brain
(r = −0.774), heart (r = −0.752), liver (r = −0.679), and spleen (r = −0.712) (all p < 0.01); these correlations
reflect changes to improve foetal viability. Conversely, lower maternal plasma concentrations of
high-density lipoprotein cholesterol (HDL-c) correlated with lower ratios of heart-to-body weight
(r = 0.677, p < 0.05). Adaptive foetal growth mechanisms were observed already on GD 70, when
lower maternal plasma cholesterol concentrations correlated with higher ratios of head-to-body
weight (r = −0.987, p < 0.005) and heart-to-body weight (r = −0.883, p < 0.05). At the same time,
maternal HDL-c concentrations correlated with higher ratios of brain-to-body weight (r = −0.923) and
spleen-to-body weight (r = −0.891, both p < 0.05).
Maternal plasma concentrations of glucose and fructosamine did not affect weight of normal
foetuses on GD 70, but they did show an influence on GD 90. Lower plasma fructosamine
concentrations correlated with lower foetal body weight (r = 0.964) as well as higher ratios of
head-to-body weight (r = −0.962) and brain-to-head weight (r = −0.969, all p < 0.05). Similarly,
lower maternal glucose levels correlated with higher ratios of head-to-body weight (r = −0.959) and
brain-to-head weight (r = −0.963, both p < 0.05).
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Table 1. Effect of age and sex on absolute weights and body measurements of male and female foetuses at Gestational Day (GD) 70 and 90. Mean values for




Same Age F vs. M Same Sex 70 vs. 90
Age × Sex
F M F M 70 90 F M
Body
morphometry
Body length (cm) 20.2 20.2 29.1 29.5 0.495 0.343 0.746 <0.001 <0.001 <0.001
Occipito-nasal length (cm) 7.7 6.6 8.4 9.2 0.403 0.045 0.193 0.241 <0.001 <0.001
Biparietal diameter (cm) 3.0 2.9 3.9 4.1 0.071 0.748 0.173 <0.001 <0.001 <0.001
Trunk diameter (cm) 2.7 2.9 4.2 4.6 0.117 0.177 0.028 <0.001 <0.001 <0.001
Trunk circumference (cm) 11.0 11.4 16.7 17.5 0.355 0.222 0.221 <0.001 <0.001 <0.001
Abdominal circumference (cm) 9.3 9.8 14.5 15.3 0.439 0.294 0.277 <0.001 <0.001 <0.001
Body weight
Body weight (g) 171.9 180.1 542.0 616.4 18.969 0.453 0.09 <0.001 <0.001 <0.001
Head weight (g) 46.8 46.6 130.4 138.9 4.086 0.948 0.340 <0.001 <0.001 <0.001




Brain weight (g) 6.5 6.5 19.9 19.9 0.378 0.968 0.996 <0.001 <0.001 <0.001
Viscerae weight (g) 26.3 27.7 86.5 96.5 3.245 0.495 0.168 <0.001 <0.001 <0.001
Heart weight (g) 1.4 1.5 4.7 5.2 0.193 0.616 0.233 <0.001 <0.001 <0.001
Lungs weight (g) 6.1 6.3 17.4 20.4 0.691 0.662 0.072 <0.001 <0.001 <0.001
Liver weight (g) 7.8 7.7 15.8 18.4 0.905 0.827 0.172 <0.001 <0.001 <0.001
Intestine weight (g) 5.2 4.9 21.7 25.2 1.089 0.599 0.187 <0.001 <0.001 <0.001
Spleen weight (g) 0.2 0.2 1.2 1.5 0.053 0.425 0.018 <0.001 <0.001 <0.001
Kidneys weight (g) 2.2 2.2 5.6 6.1 0.260 0.951 0.375 <0.001 <0.001 <0.001
a MSE = Mean square error.
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Figure 1. Metabolic profiles of sows, from which foetuses were harvested on Gestational Day (GD) 70 
or 90. Mean fasting values (mg/dL) (±SEM) of glucose, fructosamine, total cholesterol, high-density 
and low-density lipoprotein-cholesterol (HDL-c and LDL-c, respectively) and triglycerides in 
maternal plasma on the day of harvest.  
Maternal plasma concentrations of glucose and fructosamine did not affect weight of normal 
foetuses on GD 70, but they did show an influence on GD 90. Lower plasma fructosamine 
concentrations correlated with lower foetal body weight (r = 0.964) as well as higher ratios of head-
to-body weight (r = −0.962) and brain-to-head weight (r = −0.969, all p < 0.05). Similarly, lower 
maternal glucose levels correlated with higher ratios of head-to-body weight (r = −0.959) and brain-
to-head weight (r = −0.963, both p < 0.05).  
2.2. Effects of Foetal Sex on Developmental Trajectories during Pregnancy  
No significant association was observed between offspring sex and foetal weight in normal 
foetuses (Table 1), although among male foetuses collected on GD 90, we observed a trend toward 
higher total body weight (p = 0.09) and carcass weight (p = 0.06) compared to female foetuses. Fat 
content of the carcass, the longissimus dorsi muscle or the liver did not vary significantly as a function 
of foetal sex or gestational age (Table 2). 
Table 2. Effects of gestational time and sex on foetal adiposity. Mean values (%) for fat content in the 







F vs. M 
Same Sex  
70 vs. 90 
F M F M 70 90 F M 
Fat in LD (%) 0.09 0.08 0.07 0.08 0.003 0.605 0.681 0.293 0.641 
Fat in Liver (%) 0.14 0.14 0.14 0.14 0.002 0.434 0.522 0.814 0.294 
Fat in carcass 0.08 0.09 0.08 0.09 0.002 0.107 0.070 0.069 0.660 
a MSE = Mean square error. 
Male and female normal foetuses collected on GD 70 did not differ significantly in the relative 
weights or maturation states of several structures and organs. On GD 90, normal female foetuses 
showed a significantly higher degree of placental development (p < 0.05) and significantly higher 
ratios of head-to-body weight and brain-to-body weight (both p < 0.05; Figure 2). 
The comparison, on both GD 70 and 90, of foetuses with severe growth restriction and normal 
foetuses, showed smaller values than their littermates for body weight (GD 70, 126.5 ± 14.3 g vs. 183.4 
± 4.1 g, p < 0.05; GD 90, 404.5 ± 30.9 g vs. 621.8 ± 14.5 g, p < 0.005), body length (GD 70, 17.6 ± 0.9 cm 












Figure 1. Metabolic profiles of sows, from which foetuses were harvested on Gestational Day (GD) 70
or 90. ean fasting values ( dL) (±SEM) of glucose, fructosamine, total cholesterol, high-density
and lo -density lipoprotein-cholesterol (HDL-c and LDL-c, respectively) and triglycerides in maternal
plasma on the day of harvest.
2.2. Effects of Foetal Sex n Developmental Trajectories uring Pregna cy
No significant association was observed between offspring sex and foetal weight in normal
foetuses (Table 1), although among male foetuses collected on GD 90, we observed a trend toward
higher total body weight (p = 0.09) and carcass weight (p = 0.06) compared to female foetuses. Fat
content of the carcass, the longissimus dorsi muscle or the liver did not vary significantly as a function
of foetal sex or gestational age (Table 2).
Table 2. Effects of gestational time and sex on foetal adiposity. Mean values (%) for fat content in





Same Age F vs. M Same Sex 70 vs. 90
F M F M 70 90 F M
Fat in LD (%) 0.09 0.08 0.07 0.08 0.003 0.605 0.681 0.293 0.641
Fat n Liver (%) 0.14 0.14 0.14 0.14 0.002 0.434 0.522 0.814 0.294
Fat in carcass 0.08 0.09 0.08 0.09 0.002 0.107 0.070 0.069 0.660
a MSE = Mean square error.
Male and female normal foetuses collected on GD 70 did not differ significantly in the relative
weights or maturation states of several structures and organs. On GD 90, normal female foetuses
showed a significantly higher degree of placental development (p < 0.05) and significantly higher ratios
of head-to-body weight and brain-to-body weight (both p < 0.05; Figure ).
The comparison, on both GD 7 and 90, of foetuses with severe growth restriction and normal
foetuses, showed smaller values than their littermates fo body weight (GD 70, 126.5 ± 14.3 g vs.
183.4 ± 4.1 g, p < 0.05; GD 90, 404.5 ± 30.9 g vs. 621.8 ± 14.5 g, p < 0.005), body length (GD 70,
17.6 ± 0.9 cm vs. 20.5 ± 0.2 cm; GD 90, 27.0 ± 0.9 cm vs. 29.8 ± 0.4 cm; both p < 0.05), head weight
(GD 70, 35.3 ± 3.2 g vs. 48.2 ± 1 g, p < 0.05; GD 90, 103.5 ± 6.3 g vs. 141.9 ± 3.5 g, p < 0.005), carcass
weight (GD 70, 66.2 ± 8.9 g vs. 100 ± 2.9 g, p < 0.05; GD 90, 222.3 ± 18.7 g vs. 364.1 ± 9.6 g, p < 0.005)
and total weight of viscerae (GD 70, 18.2 ± 2 g vs. 28.3 ± 0.9 g, p < 0.01; GD 90, 64.3 ± 7.3 g vs.
98 ± 2.3 g, p < 0.05). However, the ratio of brain-to-body eight was significantly higher in foetuses
with severe growth restriction than in littermates on GD 70 (0.048 ± 0.004 vs. 0.036 ± 0.001) and
GD 90 (0.045 ± 0.004 vs. 0.033 ± 0.001; both p < 0.01). This was also observed when only female
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foetuses were examined (p < 0.0005 at both ages; Figure 3). On GD 90, the ratios of brain-to-body
weight and brain-to-carcass weight were significantly higher in foetuses with severe growth restriction
(both p < 0.0005), as were the ratios of liver- and spleen-to-body weight (both p < 0.05; Figure 3).
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female and male foetuses with severe IUGR, then female and male foetuses showing normal growth. 
Asterisks indicate the p value associated with differences between the foetal sexes and between 
foetuses showing IUGR or normal growth. * p < 0.05.  
2.3. Changes in Foetal Metabolism during Pregnancy and Sex-Related Effects 
Table 3 shows measurements of indicators of glucose and lipid metabolism based on markers in 
plasma, allantoic and amniotic fluids from normal foetuses. Comparison of measurements on GDs 
70 and 90 shows that the availability of foetal triglycerides significantly decreased in foetal blood  
(p < 0.05) and allantoic fluid (p < 0.005) during pregnancy. Over the same period, the availability of 
foetal triglycerides in amniotic fluid increased (p < 0.05). Low-density lipoprotein cholesterol (LDL-
c) in foetal plasma decreased during pregnancy (p < 0.005), while HDL-c increased (p < 0.001). Total 
cholesterol decreased in amniotic fluid (p < 0.0001) but increased in allantoic fluid (p < 0.005). In both 
these compartments, HDL-c and LDL-c concentrations remained unchanged during pregnancy. 
Similar results were obtained for the two foetal sexes, except that LDL-c in blood decreased to a 
greater extent in females than males (p < 0.05).  
Figure 2. Mean ratios (±SEM) of head-to-body weight (A); head-to-carcass weight (B); and
brain-to-body weight and brain-to-carcass weight (C) in female foetuses (black bars) and male foetuses
(white bars) on Gestational Day (GD) 90. Asterisks indicate significant differences between ales a
fe les. * . .
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2.3. Changes in Foetal etabolism during Pregnancy and Sex-Related Effects
Table 3 shows measurements of indicators of glucose and lipid metabolism based on markers in
plasma, allantoic and amniotic fluids from normal foetuses. Comparison of measurements on GDs
70 and 90 shows that the availability of foetal triglycerides significantly decreased in foetal blood
(p < 0.05) and allantoic fluid (p < 0.005) during pregnancy. Over the same period, the availability of
foetal triglycerides in amniotic fluid increased (p < 0.05). Low-density lipoprotein cholesterol (LDL-c)
in foetal plasma decreased during pregnancy (p < 0.005), while HDL-c increased (p < 0.001). Total
cholesterol decreased in amniotic fluid (p < 0.0001) but increased in allantoic fluid (p < 0.005). In
both these compartments, HDL-c and LDL-c concentrations remained unchanged during pregnancy.
Similar results were obtained for the two foetal sexes, except that LDL-c in blood decreased to a greater
extent in females than males (p < 0.05).
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F M F M
Same Age F vs. M Same Sex 70 vs. 90 Age × Sex





Foetal plasma 24.3 19.8 64.2 58.6 5.742 0.480 0.748 0.011 <0.001 <0.001
Amniotic fluid 29.6 23.1 24.3 26.1 1.038 0.017 0.598 0.063 0.310 0.112
Allantoic fluid 7.5 5.3 21.9 22.0 1.352 0.233 0.976 <0.001 <0.001 <0.001
Fructosamine
(mg/dL)
Foetal plasma 134.8 129.6 107.8 114.9 3.147 0.583 0.190 0.003 0.094 0.012
Amniotic fluid 48.0 44.2 57.3 57.7 1.216 0.157 0.879 0.002 <0.001 <0.001





Foetal plasma 39.4 32.2 28.3 28.6 1.804 0.204 0.938 0.081 0.437 0.154
Amniotic fluid 1.8 2.5 3.6 6.3 0.701 0.070 0.435 0.048 0.114 0.113




Foetal plasma 65.1 58.7 63.2 59.6 1.636 0.160 0.438 0.743 0.823 0.489
Amniotic fluid 4.0 3.9 2.8 2.2 0.180 0.885 0.082 0.007 0.001 <0.001
Allantoic fluid 2.7 2.5 4.5 6.3 0.417 0.636 0.310 0.051 0.004 0.003
HDL-c
(mg/dL)
Foetal plasma 12.8 13.8 21.2 18.7 0.624 0.482 0.072 <0.001 <0.001 <0.001
Amniotic fluid 2.2 2.5 2.1 2.4 0.068 0.189 0.116 0.529 0.507 0.191
Allantoic fluid 2.1 2.4 2.2 2.2 0.085 0.145 0.971 0.798 0.272 0.447
LDL-c
(mg/dL)
Foetal plasma 45.4 41.0 33.3 35.7 1.261 0.225 0.252 0.005 0.07 0.004
Amniotic fluid 3.3 3.5 3.6 3.5 0.094 0.415 0.664 0.302 0.864 0.783
Allantoic fluid 3.1 3.4 3.2 4.3 0.233 0.257 348 0.833 0.256 0.349
a MSE = Square Mean error.
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Similar changes to these described in normal foetuses were observed in the subset of foetuses
showing severe IUGR, and no sex effects were observed in this case. Foetuses with severe IUGR
showed lower plasma LDL-c concentrations than littermates on GD 90 (29.7 ± 2.5 mg/dL vs.
35.8 ± 1.03 mg/dL, p < 0.05).
2.4. Changes in Foetal Antioxidant/Oxidative Status during Pregnancy and Sex-Related Effects
Ferric reducing antioxidant power (FRAP), an index of antioxidant capacity, decreased from GD
70 (10.8 ± 1.3 µmol/mL) to GD 90 (9.9 ± 1.6 µmol/mL, p < 0.005) in samples from normal foetuses, yet
the concentration of malondialdehyde (MDA) in plasma, an index of total lipid oxidation, decreased
during the same period from 20.6 ± 0.4 mmol/mL to 15.8 ± 0.6 mmol/mL (p < 0.005). Nevertheless,
the ratio of MDA to cholesterol, which takes into account lipid availability, indicated less relative
oxidation on GD 70 than GD 90 (2.8 ± 0.9 vs. 3.5 ± 0.7). Similar results were obtained for the ratio of
MDA to LDL-c (4.1 ± 1.5 vs. 6.1 ± 1.2) and the ratio of MDA to triglycerides (5.1 ± 1.9 vs. 8.0 ± 2.8)
(all p < 0.05; Figure 4).
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Table 4. Effects of age and sex on foetal neutral fatty-acid composition of longissimus dorsi muscle. Mean values for neutral lipids in the longissimus dorsi muscle at




Same Age F vs. M Same Sex 70 vs. 90 Age × Sex
Fatty Acids (g/100 g Total Fatty Acids) F M F M 70 90 F M
C14:0 3.59 3.42 3.75 3.74 0.064 0.383 0.632 0.506 0.036 0.181
C16:0 28.97 26.79 29.33 29.25 0.375 0.069 0.549 0.809 0.001 0.021
C16:1n-9 4.22 4.35 3.46 3.38 0.102 0.625 0.46 0.018 <0.001 <0.001
C16:1n-7 3.78 4.3 7.33 7.28 0.251 0.198 0.563 <0.001 <0.001 <0.001
C17:0 0.35 0.45 0.27 0.28 0.031 0.245 0.73 0.333 0.072 0.107
C17:1 2.96 2.82 1.68 1.77 0.089 0.364 0.177 <0.001 <0.001 <0.001
C18:0 13.55 13 12.21 11.55 0.218 0.351 0.375 0.035 0.012 0.006
C18:1n-9 21.51 21.87 22.09 22.55 0.222 0.583 0.585 0.507 0.168 0.453
C18:1n-7 6.36 6.86 7.34 7.17 0.088 0.029 0.234 0.001 0.109 0.001
C18:2n-6 3.34 3.19 3.64 3.96 0.079 0.363 0.163 0.151 <0.001 0.001
C18:3n-3 0.26 0.17 0.11 0.15 0.015 0.016 0.386 0.004 0.478 0.003
C20:3n-9 0.57 0.63 0.56 0.54 0.010 0.063 0.147 0.757 <0.001 0.003
C20:3n-6 0.24 0.26 0.43 0.47 0.016 0.569 0.098 <0.001 <0.001 <0.001
C20:4n-6 5.23 6.49 4.09 4.19 0.317 0.19 0.499 0.223 0.007 0.012
C20:5n-3 0.29 0.28 0.2 0.19 0.008 0.718 0.605 <0.001 <0.001 <0.001
C22:1n-9 0.32 0.3 0.21 0.2 0.015 0.731 0.796 0.024 0.01 0.007
C22:4n-6 1.44 1.68 1.05 1.11 0.078 0.297 0.219 0.125 0.003 0.006
C22:5n-6 0.91 1.11 0.89 0.91 0.037 0.079 0.567 0.884 0.022 0.067
C22:5n-3 0.37 0.35 0.3 0.3 0.017 0.701 0.621 0.171 0.276 0.373
C22:6n-3 1.46 1.67 1.06 1.03 0.221 0.366 0.862 0.227 0.001 0.147
SFA 1 46.45 43.66 45.55 44.81 0.407 0.029 0.345 0.566 0.166 0.063
MUFA 2 39.14 40.51 42.12 42.35 0.394 0.231 0.842 0.027 0.054 0.016
PUFA 3 15.01 15.83 12.34 12.84 0.492 0.568 0.307 0.085 0.021 0.027
UI 4 0.98 1.01 0.87 0.88 0.021 0.546 0.37 0.123 0.008 0.021
PUFAn-3 5 3.27 2.48 1.67 1.67 0.232 0.3 0.686 0.143 0.001 0.057
PUFAn-6 6 2.59 3.05 2.37 2.49 0.108 0.173 0.249 0.558 0.037 0.084
∑n-6/∑n-3 0.98 1.24 1.45 1.54 0.044 0.006 0.517 0.003 <0.001 <0.001
C18:1/C18:0 2.08 2.24 2.43 2.62 0.05 0.158 0.388 0.009 0.009 0.001
MUFA/SFA 0.85 0.93 0.93 0.95 0.013 0.046 0.618 0.135 0.488 0.052
a MSE = Mean square error. 1 SFA = Saturated fatty acids; Includes: C14:0, C16:0, C17:0 and C18:0. 2 MUFA = Monounsaturated fatty acids; Includes: C16:1n-9, C16:1n-7, C17:1,
C18:1n-9, C18:1n-7 and C22:1n-9. 3 PUFA = Polyunsaturated fatty acids: Includes: C18:2n-6, C18:3n-3, C20:3n-9, C20:3n-6, C20:4n-6, C20:5n-3, C22:4n-6, C22:5n-6, C22:5n-3 and C22:6n-3.
4 UI = Conversion index. 5 Includes: C18.2n-6, C20:4n-6 and C22:4n-6. 6 Includes: C18:3n-3, C20:5n-3 and C22:6n-3.
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Table 5. Effects of age and sex on foetal polar fatty-acid composition of longissimus dorsi muscle. Mean values for polar lipids in the longissimus dorsi muscle at




Same Age F vs. M Same Sex 70 vs. 90 Age × Sex
Fatty Acids (g/100 g Total Fatty Acids) F M F M 70 90 F M
C14:0 1.99 1.83 1.83 1.84 0.067 0.396 0.944 0.448 0.95 0.827
C16:0 23.69 23.68 23.79 23.15 0.103 0.967 0.082 0.747 0.062 0.113
C16:1n-9 2.75 2.69 2.05 1.95 0.077 0.724 0.618 0.001 <0.001 <0.001
C16:1n-7 2.92 3.2 3.12 3.03 0.058 0.053 0.645 0.193 0.327 0.308
C17:0 1.11 1.06 0.99 1.06 0.031 0.659 0.42 0.018 0.977 0.713
C17:1 2.34 2.34 1.45 1.55 0.061 0.944 0.088 <0.001 <0.001 <0.001
C18:0 11.15 11.04 11.77 11.82 0.083 0.591 0.801 0.013 <0.001 <0.001
C18:1n-9 21.16 21.46 21.63 21.77 0.127 0.433 0.989 0.14 0.413 0.415
C18:1n-7 6.7 6.63 6.28 6.13 0.058 0.606 0.273 0.001 0.002 <0.001
C18:2n-6 2.76 2.61 4.03 4.19 0.110 0.235 0.44 <0.001 <0.001 <0.001
C18:3n-3 0.14 0.17 0.12 0.13 0.007 0.127 0.512 0.102 0.065 0.036
C20:1n-9 0.7 0.76 0.84 0.85 0.016 0.229 0.804 0.004 0.024 0.003
C20:3n-9 0.58 0.63 0.63 0.56 0.010 0.015 0.016 0.068 0.007 0.012
C20:3n-6 0.23 0.25 0.57 0.67 0.030 0.382 0.14 <0.001 <0.001 <0.001
C20:4n-6 12.86 12.76 12.76 13.21 0.092 0.595 0.103 0.716 0.075 0.252
C20:5n-3 0.31 0.31 0.3 0.27 0.008 0.974 0.252 0.757 0.055 0.181
C22:1n-9 0.55 0.56 0.78 0.74 0.018 0.847 0.176 <0.001 <0.001 <0.001
C22:4n-6 3.02 2.97 2.01 2.11 0.070 0.541 0.074 <0.001 <0.001 <0.001
C22:5n-6 1.35 1.38 1.19 1.24 0.024 0.704 0.65 0.02 0.038 0.019
C22:5n-3 0.72 0.68 0.69 0.62 0.015 0.308 0.285 0.526 0.157 0.180
C22:6n-3 2.98 2.99 3.16 3.09 0.028 0.932 0.355 0.055 0.148 0.101
SFA 1 37.94 37.63 38.39 37.87 0.692 0.447 0.261 0.216 0.568 0.467
MUFA 2 37.12 37.63 36.15 36.03 0.681 0.256 0.427 0.002 0.002 0.904
PUFA 3 24.95 24.74 25.47 26.09 0.477 0.401 0.215 0.219 0.002 0.195
UI 4 1.39 1.39 1.37 1.39 0.025 0.879 0.257 0.24 0.815 0.655
PUFAn-3 5 4.15 4.15 4.27 4.11 0.083 0.993 0.268 0.329 0.725 0.568
PUFAn-6 6 20.23 19.96 20.56 21.42 0.399 0.283 0.118 0.448 0.001 0.123
∑n-6/∑n-3 4.9 4.84 4.84 5.24 0.064 0.647 0.081 0.769 0.016 0.085
C18:1/C18:0 0.45 0.43 0.48 0.47 0.004 0.168 0.908 0.001 0.001 <0.001
MUFA/SFA 0.98 1 0.94 0.95 0.008 0.298 0.733 0.008 0.031 0.013
a MSE = Mean square error. 1 SFA = Saturated fatty acids; Includes: C14:0, C16:0, C17:0 and C18:0. 2 MUFA = Monounsaturated fatty acids; Includes: C16:1n-9, C16:1n-7, C17:1. C18:1n-9,
C18:1n-7, C20:1n-9 and C22:1n-9. 3 PUFA = Polyunsaturated fatty acids: Includes: C18:2n-6, C18:3n-3, C20:3n-9, C20:3n-6, C20:4n-6, C20:5n-3, C22:4n-6, C22:5n-6, C22:5n-3 and C22:6n-3.
4 UI = Conversion index. 5 Includes: C18.2n-6, C20:4n-6 and C22:4n-6. 6 Includes: C18:3n-3, C20:5n-3 and C22:6n-3.
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During pregnancy, male normal foetuses showed increases in myristic acid (C14:0, p < 0.05),
palmitic acid (C16:0, p < 0.001) and linoleic acid (C18:2n-6, p < 0.001), while female normal foetuses
showed increases in cis-vaccenic acid (C18:1n-7, p < 0.01) and total MUFA (p < 0.05). During pregnancy,
male foetuses showed decreases in mead acid (C20:3n-9, p < 0.001), adrenic acid (C22:4n-6, p < 0.005),
arachidonic acid (C20:4n-6, p < 0.01), docosapentaenoic acid (C22:5n-6, p < 0.05), total PUFA (p < 0.05),
and the unsaturated index (UI; p < 0.01). Female foetuses showed a significant decrease in α-linolenic
acid (p < 0.005).
Sex-specific differences were also observed in the composition of the polar fatty acid fraction
of normal foetuses. Female foetuses had less palmitoleic, α-linolenic and mead acids than males
(all p < 0.05) on GD 70 and 90. During pregnancy, several fatty acids increased significantly in both
sexes, including stearic, α-linoleic, homo-γ-linolenic and erucic acids (all p < 0.0001); docosahexaenoic
acid (C22:6n-3, p < 0.05); total PUFA (p < 0.05); n-6 PUFA (p < 0.05); and the C18:1/C18:0 ratio
(p < 0.0001). Over the same period, several fatty acids decreased significantly in both sexes, including
cis-7 hexadecenoic, heptadecanoic, cis-vaccenic, α-linolenic, adrenic and docosapentaenoic acids (all
p < 0.005); and the MUFA/SFA ratio (p < 0.001). Female foetuses showed a significant decrease in
heptadecanoic acid (p < 0.05), while males showed a significant decrease in mead acid (p < 0.05) and
an increase in ∑n-6/∑n-3 ratio (p < 0.05).
2.6. Changes in Foetal Liver Composition during Pregnancy and Sex-Related Effects
Like the intramuscular fatty acid composition, the neutral fatty acid composition of the liver of
normal foetuses varied significantly with gestational age and foetal sex (Table 6). During pregnancy,
several fatty acids increased in both sexes, including myristic, palmitic, palmitoleic, vaccenic and
α-linoleic acids (all p < 0.0001); mead acid (p < 0.005); adrenic acid (p < 0.001); and the C18:1/C18:0
ratio (p < 0.005). Over the same period, several fatty acids decreased in both sexes: margaric (C17:0),
heptadecanoic, stearic, and α-linolenic acids (all p < 0.0001), as well as erucic acid (p < 0.0005). In male
foetuses, arachidonic and eicosapentaenoic acids decreased (both p < 0.05), while in females, total SFA
decreased (p < 0.01).
On GD 70 and 90, female foetuses showed higher amounts of stearic acid and total SFA
(both p < 0.05), but lower amounts of cis-7 hexadecenoic acid (p < 0.005), oleic acid (p < 0.05), and
MUFA (p < 0.01), as well as lower ratios of C18:1/C18:0 (p < 0.01) and MUFA/SFA (p < 0.005). On GD
70, females showed higher content of heptadecanoic acid (p < 0.05) and lower content of cis-vaccenic
acid (p < 0.01) than males. On GD 90, females showed lower content of heptadecanoic acid (p < 0.05)
than males.
In contrast, the composition of the polar fatty acid fraction did not vary significantly between
male and female normal foetuses (Table 7), with the exception that α-linoleic acid content was higher in
females than males on GD 70 (p < 0.05). During pregnancy, both sexes showed increases in arachidonic
acid (p < 0.0005); margaric, stearic, linoleic, and mead acids (all p < 0.0001); myristic acid (p < 0.05);
total PUFA and n-6 PUFA (both p < 0.0001); and UI (p < 0.005). During the same period, both sexes
showed decreases in α-linolenic, erucic, cis-7 hexadecenoic and heptadecanoic acids (all p < 0.0001);
oleic acid (p < 0.005); vaccenic acid (p < 0.05); total MUFA (p < 0.0001); and the ratios C18:1/C18:0 and
MUFA/SFA (both p < 0.0005).
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Table 6. Effects of age and sex on foetal neutral fatty-acid composition of liver. Mean values for neutral lipids in the liver at Gestational Day (GD) 70 and 90 in




Same Age F vs. M Same Sex 70 vs. 90 Age × Sex
Fatty Acids (g/100 g Total Fatty Acids) F M F M 70 90 F M
C14:0 1.82 1.61 2.93 3.24 0.128 0.391 0.378 <0.001 <0.001 <0.001
C16:0 19.02 19.67 23.14 23.25 0.336 0.345 0.945 <0.001 <0.001 <0.001
C16:1n-9 1.58 2.03 1.84 2.08 0.063 0.016 0.153 0.101 0.77 0.016
C16:1n-7 6.8 7.31 8.66 9.34 0.196 0.192 0.289 <0.001 <0.001 <0.001
C17:0 3.5 3.06 1.6 1.59 0.125 0.028 0.887 <0.001 <0.001 <0.001
C17:1 2.19 2.29 1.22 1.36 0.072 0.392 0.049 <0.001 <0.001 <0.001
C18:0 22.89 18.94 16.22 14.77 0.656 0.031 0.191 0.001 0.008 <0.001
C18:1n-9 18.94 19.8 17.67 20.68 0.376 0.365 0.04 0.249 0.383 0.059
C18:1n-7 5.6 6.42 7.16 6.87 0.125 0.011 0.26 <0.001 0.166 <0.001
C18:2n-6 2.29 2.39 3.24 3.14 0.085 0.533 0.92 <0.001 <0.001 <0.001
C18:3n-3 0.37 0.36 0.26 0.26 0.010 0.783 0.808 <0.001 <0.001 <0.001
C20:1n-9 0.26 0.41 0.24 0.25 0.045 0.361 0.998 0.6 0.319 0.451
C20:3n-9 0.29 0.29 0.37 0.32 0.009 0.841 0.216 0.003 0.126 0.004
C20:4n-6 12.16 12.99 12.98 10.61 0.373 0.344 0.169 0.488 0.018 0.084
C20:5n-3 0.1 0.11 0.08 0.26 0.033 0.811 0.3 0.411 0.172 0.221
C22:1n-9 0.47 0.37 0.28 0.24 0.022 0.087 0.689 0.007 0.011 0.001
C22:4n-6 0.43 0.43 0.66 0.54 0.023 0.938 0.169 0.011 0.012 0.001
C22:5n-3 0.84 1.12 0.95 0.78 0.049 0.069 0.17 0.334 0.025 0.038
C22:6n-3 0.43 0.4 0.51 0.4 0.018 0.519 0.194 0.152 0.918 0.164
SFA 1 47.23 43.28 43.89 42.85 0.467 0.009 0.029 0.009 0.726 0.002
MUFA 2 35.84 38.63 37.07 40.83 0.564 0.04 0.107 0.445 0.138 0.014
PUFA 3 16.93 18.09 19.04 16.32 0.469 0.314 0.215 0.157 0.164 0.234
UI 4 1 1.08 1.08 1.01 0.016 0.087 0.253 0.093 0.128 0.145
SUMN3 5 1.75 1.99 1.8 1.7 0.063 0.155 0.793 0.697 0.138 0.267
SUMN6 6 14.89 15.81 16.88 14.3 0.422 0.362 0.204 0.151 0.179 0.220
N6/N3 8.58 8.23 9.41 8.77 0.199 0.463 0.453 0.108 0.357 0.225
SUMC18:1/C18:0 1.12 1.47 1.57 1.93 0.063 0.011 0.103 0.003 0.006 <0.001
MUFA/SFA 0.77 0.91 0.85 0.95 0.019 0.007 0.067 0.096 0.321 0.002
a MSE = Mean square error. 1 SFA = Saturated fatty acids; Includes: C14:0, C16:0, C17:0 and C18:0. 2 MUFA = Monounsaturated fatty acids; Includes: C16:1n-9, C16:1n-7, C17:1.
C18:1n-9, C18:1n-7 and C22:1n-9. 3 PUFA = Polyunsaturated fatty acids: Includes: C18:2n-6, C18:3n-3, C20:3n-9, C20:3n-6, C20:4n-6, C20:5n-3, C22:4n-6 C22:5n-6, C22:5n-3 and C22:6n-3.
4 UI = Conversion index. 5 Includes: C18.2n-6, C20:4n-6 and C22:4n-6. 6 Includes: C18:3n-3, C20:5n-3 and C22:6n-3.
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Table 7. Effects of age and sex on foetal polar fatty-acid composition of liver. Mean values (%) for polar lipids in the liver at Gestational Day (GD) 70 and 90 in




Same Age F vs. M Same Sex 70 vs. 90 Age × Sex
Fatty Acids (g/100 g Total Fatty Acids) F M F M 70 90 F M
C14:0 1.73 1.66 1.89 1.8 0.033 0.45 0.524 0.168 0.084 0.088
C16:0 22.83 21.93 23.13 22.39 0.217 0.184 0.188 0.689 0.389 0.215
C16:1n-9 1.77 1.73 1.34 1.39 0.038 0.638 0.197 0.001 <0.001 <0.001
C16:1n-7 5.11 4.84 5.11 4.96 0.064 0.162 0.561 0.999 0.502 0.351
C17:0 3.09 3.05 1.72 1.75 0.100 0.764 0.797 <0.001 <0.001 <0.001
C17:1 1.7 1.7 0.86 0.83 0.064 0.988 0.435 <0.001 <0.001 <0.001
C18:0 18 18.08 19.17 19.93 0.165 0.819 0.165 0.014 <0.001 <0.001
C18:1n-9 14.09 13.7 12.08 12.18 0.274 0.583 0.963 0.021 0.032 0.016
C18:1n-7 8.03 8.19 7.28 7.13 0.204 0.784 0.727 0.176 0.077 0.158
C18:2n-6 2.38 2.15 2.82 2.68 0.055 0.033 0.549 0.005 0.001 <0.001
C18:3n-3 0.32 0.32 0.2 0.2 0.014 0.97 0.652 0.004 0.001 <0.001
C20:1n-9 0.17 0.17 0.18 0.18 0.004 0.978 0.266 0.388 0.842 0.824
C20:3n-9 0.3 0.3 0.39 0.4 0.010 0.768 0.751 0.01 <0.001 <0.001
C20:4n-6 17.07 18.57 19.88 20.36 0.300 0.076 0.231 0.004 0.009 <0.001
C20:5n-3 0.15 0.13 0.23 0.21 0.012 0.625 0.622 0.032 0.011 0.007
C22:1n-9 0.4 0.43 0.29 0.3 0.015 0.549 0.591 0.003 0.002 <0.001
C22:4n-6 0.56 0.53 0.92 0.83 0.041 0.674 0.543 0.016 0.001 0.001
C22:5n-3 1.57 1.8 1.68 1.73 0.069 0.262 0.918 0.557 0.74 0.678
C22:6n-3 0.72 0.71 0.84 0.76 0.023 0.907 0.23 0.145 0.429 0.279
SFA 1 45.66 44.72 45.92 45.87 0.305 0.321 0.873 0.797 0.157 0.405
MUFA 2 31.27 30.76 27.13 26.97 0.461 0.64 0.822 0.002 0.002 <0.001
PUFA 3 23.07 24.51 26.95 27.16 0.376 0.148 0.576 0.001 0.003 <0.001
UI 4 1.21 1.27 1.32 1.33 0.012 0.108 0.462 0.007 0.047 0.002
SUMN3 5 2.76 2.96 2.95 2.9 0.072 0.366 0.779 0.373 0.772 0.752
SUMN6 6 20.01 21.25 23.61 23.86 0.332 0.134 0.492 0.001 0.001 <0.001
N6/N3 7.4 7.62 8.19 8.3 0.221 0.749 0.714 0.126 0.33 0.446
SUMC18:1/C18:0 1.23 1.22 1.02 0.98 0.033 0.85 0.623 0.026 0.005 0.004
MUFA/SFA 0.69 0.69 0.59 0.59 0.014 0.922 0.895 0.019 0.007 0.515
a MSE = Mean square error. 1 SFA = Saturated fatty acids; Includes: C14:0, C16:0, C17:0 and C18:0. 2 MUFA = Monounsaturated fatty acids; Includes: C16:1n-9, C16:1n-7, C17:1.
C18:1n-9, C18:1n-7 and C22:1n-9. 3 PUFA = Polyunsaturated fatty acids: Includes: C18:2n-6, C18:3n-3, C20:3n-9, C20:3n-6, C20:4n-6, C20:5n-3, C22:4n-6, C22:5n-6, C22:5n-3 and C22:6n-3.
4 UI = Conversion index. 5 Includes: C18.2n-6, C20:4n-6 and C22:4n-6. 6 Includes: C18:3n-3, C20:5n-3 and C22:6n-3.
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3. Discussion
The results of the present study support the prominent role of the maternal metabolic profile
on foetal development and homeorhesis and provide new insights on the effects of offspring sex
on fetoplacental development, lipid availability and fatty acid composition at non-adipose tissues
involved in metabolism regulation (muscle and liver). These data may be considered relevant for
humans since despite differences in placentation, human and pig foetuses and pregnant females show
similar lipid metabolism and distribution [39].
In the current study, lower cholesterol concentration in maternal plasma correlated with
deficiencies in foetal development, which it is consistently with previous studies on GD 42 [16].
In contrast, poor availability of glucose, the main energy source for developing foetuses [40], affected
foetal development on GD 90 but not on GD 70 in our study, consistent with reports that hypoglycaemia
in early development is non-critical and can be compensated [41].
The higher growth of the brain when compared to total body observed in the foetuses affected by
IUGR is consistent with the “brain-sparing effect” firstly described by Rudolph (1984) [42]. There was
also a higher growth of other organs (mainly heart, liver and spleen), which is also consistent with
studies in humans documenting “heart- and liver-sparing” cardiovascular adaptations—analogous
to the brain-sparing effect—in response to foetal malnutrition and hypoxia [43,44]. Previous studies
address that changes in the growth, morphology and function of various organs are dependant on the
timing and severity of nutritional restriction [45,46], with specifically a determinant effect triggered
by lipid availability. At the same time, our results support previous work indicating sex-specific
differences in the growth of the different organs [27,31].
Maternal undernutrition in our study clearly affected foetal lipid availability. The developing
foetus and placenta require large amounts of lipids for: (a) synthesis of cholesterol, which acts as a
key constituent of cell membranes and organelles and is the precursor of a range of hormones and
metabolic regulators necessary for successful pregnancy [47–50]; (b) secretion of key products such
as lipoproteins; and (c) storage of triglycerides [47–49]. Although placental and foetal tissues can
synthesize lipids de novo [47,51], the building blocks must be taken up by the placenta, i.e. maternal
free fatty acids; triglycerides, which placental lipases hydrolyse into fatty acid constituents; and
lipoprotein-associated cholesterol [19,21,23,51]. Triglycerides are a major source of energy for the
foetus [52,53], but a balance is needed: low levels of triglycerides delay growth, while high levels
can cause foetal macrosomia [54]. Availability of lipids to the fetoplacental unit depends on de novo
synthesis by the foetus as well as maternal transfer. Cholesterol, for example, can reach the foetal
circulatory system after crossing the syncytiotrophoblast as LDL-c [49,55]. In pig foetuses, fatty acid
availability and composition depend more on foetal synthesis from precursors transferred from the
mother than on direct maternal transfer [56–61], since fatty acids do not easily cross the placenta in
ruminants, pigs or horses [62].
Lipid availability to the foetoplacental unit also depends on the antioxidant/oxidative status
of the foetus. Our results suggest that, during pregnancy, antioxidant capacity decreases and lipid
peroxidation increases in foetuses affected by maternal undernutrition, as suggested by previous
studies [24–26]. These changes may explain the lower lipid availability later in pregnancy.
Cholesterol and triglyceride availability in our study did not differ significantly between male
and female foetuses, consistently with prior studies [56]. Our data further show that the two sexes
showed similar antioxidant capacity and lipid peroxidation. In other words, foetal development was
affected to a much greater extent by gestational age—and therefore by nutritional restriction—than
by sex. Nevertheless, we did observe sex-related differences in how the fatty acid composition of
non-adipose tissues involved in metabolism regulation (muscle and liver) changed between GD 70
and 90 in foetuses affected by maternal undernutrition.
Our data indicate significant sex-related differences in content of essential fatty acids, which are
so-called because they must be obtained from maternal transfer in the case of foetuses [22,63] or from
diet in the case of adults [64]. The major essential fatty acids are linolenic PUFA (an omega-3 fatty
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acid) and linoleic PUFA (an omega-6 fatty acid); the long-chain omega-3 PUFA eicosapentaenoic and
docosahexaenoic acids and the long-chain omega-6 PUFA gamma-linolenic and arachidonic acids are
also essential. Future work should examine the maternal and/or placental factors that may drive the
sex-dependent differences in essential fatty acid availability that we observed.
Most of the differences in fatty acid composition between male and female foetuses that we
observed in muscle and liver belonged to the neutral fraction corresponding to triglycerides, which are
an essential energy source [19]. Smaller differences were observed in the polar fraction corresponding
to phospholipids, which constitute cell membranes and are essential for tissue development [19],
so sex-related differences in fatty acid composition are most related to energy partitioning than to
organ development.
We found that male foetuses had a higher n-6/n-3 ratio than females, and a high n-6/n-3 ratio
appears to be deleterious [65], corresponding to the prodromal phase of insulin resistance [66]. Optimal
development depends on adequate availability of n-6 [67], while n-3 may improve insulin function.
Our results are consistent with previous reports that alterations in lipid metabolism and insulin
regulation appear early in the development of male foetuses under limited nutrition [68–71]. Indeed,
males in our study showed a significantly higher ratio of MUFA to SFA in muscle triglycerides than
females on GD 70, although this difference was no longer significant on GD 90. On GD 70 and 90,
males showed lower stearic acid content in the liver, and this acid is considered to protect metabolic
health [72,73]. Males also showed higher ratios of MUFA to SFA and C18:1 to C18:0, indicating higher
stearoyl-CoA desaturase activity. Although we observed few sex-related differences in the changes
in phospholipid composition of muscle or liver during pregnancy, we did observe that females had
higher content of linoleic acid in the liver than males on GD 70, and that males had higher content of
mead acid in the muscle on GD 70 and 90. The greater content of mead acid in males likely reflects a
worse homeorhesis state, since synthesis of mead or eicosatrienoic acid occurs in response to severe
deficiency of fatty acids, mainly linoleic acid [74,75].
4. Material and Methods
4.1. Ethics Statement
These experiments were performed according to the Spanish Policy for Animal Protection
RD53/2013, which complies with the European Union Directive 2010/63/UE on the protection of
animals used for research. The experimental procedures were specifically assessed and approved
by the INIA Committee of Ethics in Animal Research (report CEEA 2013/036, finally approved on
19 February 2014). Sows were housed in INIA animal facilities, which meet local, national and
European requirements for Scientific Procedure Establishments.
4.2. Animals and Experimental Procedures
The study involved a total of 56 foetuses obtained from 9 multiparous purebred Iberian sows
with an average body weight of 147.7 ± 16.0 kg, which became pregnant after cycle synchronization
with altrenogest (Regumate®, MSD, Boxmeer, The Netherlands) and insemination with cooled semen
from a purebred Iberian boar. All sows and the boar were homozygous for the LEPRc.1987T allele
based on pyrosequencing [76].
Sows were fed with a standard grain-based food diet with the following mean component values:
dry matter, 89.8%; crude protein, 15.1%; fat, 2.8%; and metabolizable energy, 3.0 Mcal/kg. Diet analysis
(Table 8) showed that the most abundant fatty acids (FA) were palmitic (18.7%), oleic (23.2%) and
linoleic acids (46.5%).
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The amount of food was adjusted to fulfil individual daily maintenance requirements, based
on data from the British Society of Animal Science, from the start of the experimental period until
GD 35 [77]. On this day, all sows were weighed and the amount of food offered to each sow was
adjusted to fulfil 50% of their daily maintenance requirements, which has been shown to increase
IUGR incidence [78]. Every day, a single food ration was weighed out and given to each sow in her
individual pen; hence, the diet of each female was adjusted to her own weight.
Foetuses were obtained on GD 70 from five sows or on GD 90 from four sows. These gestational
time points correspond to approximately 60% and 80% of a 112-day gestation typical for this breed,
corresponding to 24 and 32 weeks of human pregnancy, respectively. These time points were chosen
because until GD 70 of swine pregnancy, lipid anabolism and foetal metabolism resemble maternal
metabolism [79]; around GD 90, foetal metabolism is independently regulated, and foetal development
is more affected by nutrient availability [80].
On GD 70 and 90, blood samples were drawn from the orbital sinus of sows that had fasted for
approximately 16 h. Samples were collected in sterile, heparinised 4-mL vacuum tubes (Vacutainer™
Systems Europe, Meylan, France) and were immediately centrifuged at 1500 g for 15 min. The plasma
was separated and biobanked into polypropylene vials at −80 ◦C until they were assayed for metabolic
biomarkers including glycaemic values and lipid profile.
4.3. Sampling of Placentas and Foetuses
Animals were euthanised by stunning and exsanguination, in compliance with RD53/2013
standard procedures, and the entire genital tracts were immediately collected for morphometric
evaluation and foetal sampling. The contents of the uterus were exposed, and conceptus position
was recorded. In each normal non-IUGR foetus, the allantoic and amniotic fluids were obtained
by aspiration through the chorioallantoic and amniochorionic membranes, and blood samples were
drawn from the heart and/or umbilical cord using heparinised syringes. Blood was processed as
described above for sows, while allantoic and amniotic fluids were centrifuged at 1500× g for 15 min
and supernatants were biobanked into polypropylene vials at −80 ◦C until they were assayed for
metabolic biomarkers (including glycaemic values and lipid profile) and antioxidant/oxidative status.
Rectangular sections of the uterine wall were collected, fixed in 4% paraformaldehyde, embedded in
paraffin and stained using hematoxylin-eosin. Individual sections of the placentas were measured
morphometrically as described [81] to obtain the average width of the placental folds, which served as
an index of placental maturation.
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4.4. Evaluation of Foetal Sex and Morphological Features
Foetal sex was determined by visual inspection immediately after recovery; detailed
pregnancy-by-pregnancy information is shown in Table 9. Body length (crown-rump length), head size
(occipito-nasal length and biparietal diameter) and corpulence (thoracic and abdominal circumferences)
were measured in all the normal and IUGR foetuses. Total foetus weight was determined, then the
head was separated from the trunk at the atlanto-occipital union, and head and trunk were weighed
separately. All viscerae were obtained and weighed together immediately, and then the brain, heart,
lungs, liver, intestine, kidneys, spleen and pancreas were weighed separately. Ratios of head-to-body
weight, brain-to-head weight, and the weight of total viscera and individual organs (brain, heart, lungs,
liver, kidneys, intestine, pancreas, and spleen) relative to body weight were calculated.
Table 9. Detailed information (total number and percentage) on sex distribution (total, male and female
foetuses) in the pregnancies studied in the current trial.
Sow ID GD
Distribution of Foetuses
T (n) F (n) F (%) M (n) M (%)
1331 70 5 2 40.0 3 60.0
1335 70 13 5 38.5 8 61.5
1346 70 7 3 42.9 4 57.1
1347 70 3 1 33.3 2 66.7
1418 70 5 3 60.0 2 40.0
1339 90 4 1 25.0 3 75.0
1402 90 11 5 45.5 6 54.5
1411 90 5 2 40.0 3 60.0
1416 90 3 2 66.7 1 33.3
Samples from liver, kidneys, duodenum and ileum were fixed in 4% paraformaldehyde,
embedded in paraffin and stained with hematoxylin-eosin. The degree of maturation of these organs
was assessed by evaluating the number of glomeruli with a well-defined glomerular tuft in the
kidney [82], the decrease of hepatic haematopoiesis in the liver [83] and villus height and crypt depth
in the intestine [84]. This assessment was made by an investigator blinded to sow and foetus details.
4.5. Evaluation of Maternal and Foetal Metabolic Status
Lipid profile parameters (triglycerides, total cholesterol, HDL-c, LDL-c) were measured in
maternal plasma as well as in plasma, allantoic and amniotic fluids of normal foetuses. Assays
were performed using a clinical chemistry analyser (Saturno 300 plus, Crony Instruments s.r.l., Rome,
Italy), according to the manufacturer’s instructions.
4.6. Evaluation of Foetal Adiposity and Fat Composition
Total fat was quantified in carcasses, and the total fat percentage and fatty acid composition
(in g/100) were determined in intramuscular fat and liver of normal foetuses. For this purpose,
samples from longissimus dorsi muscle and the left liver lobe were biobanked at −80 ◦C until they were
assayed as described [85]. Intramuscular fat and liver fat were extracted from 300 mg of lyophilised
and homogenised samples using the Ball-mill procedure [86]. Fatty acids in the total lipid extracts
were identified and quantified by gas chromatography (HP6890, Hewlett Packard, Avondale, PA, USA)
after methylation, as described in [87,88]. Fatty acid methyl esters were fractionated on a cross-linked
polyethylene glycol capillary column (30 cm × 0.32 mm × 0.25 µm, Hewlett Packard Innowax) and
a temperature gradient from 170 ◦C to 245 ◦C. The injector and detector were maintained at 250 ◦C.
Neutral lipid fractions (triglycerides) and polar lipid fractions (phospholipids) were analysed using
gas chromatography after passing them through aminopropyl minicolumns previously activated
with 7.5 mL of hexane as described [89]. The percentages of individual fatty acids were used to
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calculate proportions of SFA, MUFA and PUFA, as well as total n-3 and n-6 and their ratio (∑n-6/∑n-3).
The unsaturation index (UI) was obtained from the ratio of MUFA to SFA, and the activity of the
stearoyl-CoA desaturase enzyme 1 was inferred from the ratio of the enzyme product, oleic acid
(C18:1n-9), to the enzyme substrate, stearic acid (C18:0).
4.7. Evaluation of Foetal Antioxidant/Lipid Oxidative Status
In normal foetuses, values for total antioxidant capacity were assayed using the ferric reducing
antioxidant power assay (FRAP) as previously described [90], while lipid peroxidation was assessed
by measuring MDA (mmol/mL) using the thiobarbituric acid reaction and HPLC separation with
fluorescence detection as previously described [91].
4.8. Statistical Analyses
Data were analysed using SPSS 22.0 (IBM Corp., Armonk, NY, USA). Based on previous
studies [42], foetuses with severe growth restriction were defined as those with a body weight more
than one standard deviation below the litter mean value. Among the 33 foetuses collected on GD 70,
four (11%) were classified as showing severe growth restriction. Among the 23 foetuses collected on
GD 90, four (17.4%) were so classified. Effects of gestational age (GD 70 vs. 90), sex (female vs. male)
and growth restriction on developmental traits, adiposity, fatty-acid composition, and metabolic and
foetal oxidative status were assessed by two-way ANOVA. Duncan’s post-hoc test was performed to
check differences among groups in multiple comparisons. Relationships between maternal metabolic
biomarkers and features of foetuses showing normal growth were explored using Pearson correlation.
The sow was considered the experimental unit for all variables in order to avoid biasing the results
according to litter size: foetuses with the same sex and development (normal or IUGR) from the same
sow were averaged together, giving one data point per sow. All results were expressed as mean ± SEM
and statistical significance was accepted from p < 0.05.
5. Conclusions
The present study supports the importance of the maternal lipid profile and placental transfer of
lipids, mainly essential fatty acids, for foetal development, and it confirms and extends previous studies
suggesting that female foetuses show better adaptive responses in the form of greater synthesis of
non-essential fatty acids and better transfer of essential fatty acids, resulting in better metabolic indexes.
These sex-related differences were observed primarily in the neutral lipid fraction (triglycerides),
suggesting a strong influence of sex on postnatal energy partitioning. These results may help guide
future studies on understanding and optimising the maternal diet and placenta transfer capacity in
order to meet foetal requirements for fatty acids and prevent the postnatal problems associated with
insufficient prenatal fatty acid availability.
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